Shares of Theralase Technologies Inc. (CVE:TLT – Get Free Report) dropped 13.5% during trading on Monday . The company traded as low as C$0.15 and last traded at C$0.16. Approximately 1,437,130 shares changed hands during mid-day trading, an increase of 1,326% from the average daily volume of 100,774 shares. The stock had previously closed at C$0.19.
Theralase Technologies Price Performance
The stock has a market capitalization of C$41.13 million, a PE ratio of -8.89 and a beta of -0.22. The firm’s fifty day moving average price is C$0.19 and its two-hundred day moving average price is C$0.20. The company has a quick ratio of 3.40, a current ratio of 1.91 and a debt-to-equity ratio of 14.85.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
See Also
- Five stocks we like better than Theralase Technologies
- What is a Bond Market Holiday? How to Invest and Trade
- Insiders Are Snapping Up This AI Stock—Is a Big Bounce Coming?
- What is a Microcap Stock? Everything You Need to Know
- These 2 Energy Titans Just Scored Major Wins to Close Out November
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Analog Devices Moves Higher as Super-Cycle Gains Momentum
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
